Mean time to CD19 repletion was 2.17 1.17 (range 1–4) mo and all the subjects received further therapy (median doses 2.5, range 2–4). aPLA2R, m-type phospholipase A2 receptor antibody; cCTX/GC, cyclical cyclophosphamide and steroids; F/U, follow-up; IST, immunosuppressive therapy; RTX, rituximab; Sr Alb, serum albumin; TAC, tacrolimus; UP, urine protein. Patient developed upper respiratory trac...
